Navigation Links
Survey: Parents Let Their Own Experiences Affect Drug and Alcohol Boundaries Set for Teens at Prom and Graduation Parties
Date:5/29/2008

Teens Say Prescription Drug Abuse Also May Be Part of the Festivities

NEW YORK, May 29 /PRNewswire-USNewswire/ -- A new survey released today from the Partnership for a Drug-Free America(R) and MetLife Foundation found that parents' personal past experiences with alcohol and drugs at prom and graduation parties may influence the rules and limits they set for their teens during this time of the year.

According to the survey, parents who drank or used drugs at their own proms or graduations were likely to be more permissive with their kids than those parents who did not. Among parents who drank or used drugs on these occasions, 66 percent set a "zero tolerance policy" for their teens. Among parents who did not drink or use drugs, that number jumps up to 87 percent of parents who set hard rules about drinking and drugs for their kids. Parents who abused drugs or alcohol are also more likely to suspect that teens will use drugs or drink at prom or graduation parties - 51 percent versus just 36 percent of parents who didn't use drugs or alcohol.

The survey also indicates that when parents talk to kids about alcohol and drug abuse teens take their parents' messages to heart - only 16 percent of teens whose parents set a zero tolerance policy reported their individual likelihood of using drugs or alcohol, whereas 45 percent of teens whose parents didn't set such boundaries reported they were likely to drink or use drugs at prom or graduation parties this year.

"Parents can't let past drug use or personal experiences at their prom parties influence their attitudes toward their kids' use today," said Steve Pasierb, president and CEO of the Partnership. "The drug abuse landscape teens face today - which includes abuse of prescription and over-the-counter medicines - is drastically different than when today's parents were teens. We know that parents are the greatest point of leverage in preventing drug and alcohol abuse, and this survey reinf
'/>"/>

SOURCE MetLife Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement
2. New National Survey: 84% of Americans Over 50 Expect a Family Member to Move into an Assisted Living Community Within the Next 10 Years
3. Survey: Employers Have High Confidence They Can Control Health Care Costs With Proper Tools
4. 18th Annual Retirement Confidence Survey:(R) Workers Show Record Drop in Retirement Confidence, Health Care and Economy Are Major Concerns
5. National Healthcare Decisions Survey: Its Easier to Talk About Drugs and Sex Than End-of-Life Planning
6. Guardian Survey: Despite Perceived Effectiveness, Most Employees Who Participate in Wellness Programs Do Not Stay Committed
7. Survey: Most People Unsure About Cloned Food
8. Survey: 35% of Baby Boomer Nurses Plan a Career Change in the Next One to Three Years
9. Survey: Massachusetts Employers, Employees Paying Most for Health Care Plans
10. Survey: Two-thirds of Illinois public schools provide comprehensive sex education
11. Parents survey: Perceptions of the duration of their childs ADHD medication

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , , KNOXVILLE, Tenn., Dec. 2 /PRNewswir...s presence in Southwest Florida with the acquisiti... LLC (EPN). Since January 2002, EPN has held an e...aff the emergency facilities at the Downtown Naple...ealthcare Clinic. EPN also provides the staffing f...
(Date:12/2/2009)... , Waltham, MAJoseph Balboni loves sports. An avi...n, the 46-year-old insurance agent became increasi...ue to keratoconus, a degenerative eye disorder. Un... Red Sox games, he faced the prospect of a corneal... , Then three years ago, Balboni discovered an a...
(Date:12/2/2009)... , EUROECHO 2009 is the official congress of the ...registered branch of the European Society of Cardi... imaging will be presented. , New case reports ...e latest evidence highlighting the role of this ne...t in imaging techniques, it is likely that non-inv...
(Date:12/2/2009)... , National Pen ( www.pen...retailer, announced today it is giving away 10,000... (PRWEB) December 2, 2009 -- National Pen ( www....ts retailer announced today it is giving away 10,0...ve a new way to promote business that no other com...
(Date:12/2/2009)... , Revolutionary new cell... away from users will be available in early 2010 f... (PRWEB) December 2, 2009 -- Revolutionary ...missions away from users will be available in earl...gy was recently honored with a Green Technology Aw...
Breaking Medicine News(10 mins):Health News:TeamHealth Acquires Emergency Physicians of Naples, LLC 2Health News:Brandeis studies evaluate visionary approach to improving eyesight 2Health News:Media alert: EUROECHO 2009 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2
...,s revised statistics regarding new HIV infections...://www.requestatest.com/ [HIV testing __title__ H...ons infected don,t know they carry the HIV virus. ...decade. This was the surprising announcement made ...
...rma, Inc.,(Amex: DDD ) announced today that it ha... Abbreviated New Drug Application (ANDA) for a 120... the Company,s patented,Controlled Delivery Techno...ra(R) D, Sudafed(R),PSE, Claritin(R) D, Zyrtec(R) ...
...Technology Investments Streamline Processes, Acc...dy, NASHVILLE, Tenn., Aug. 5 HealthLeaders-Inter...ntelligence, reports that Health,Care Service Corp...lue Profiler: Health Care Service Corporation, the...
...,Therapeutics (Nasdaq: NKTR ) today announced the... the position of Senior Vice President of Drug,Dev...ugust 11, 2008. Dr.,Moreadith will report to Nekta...and Regulatory Affairs at Nektar. He is,responsibl...
...aceutical,Services, Inc. (NYSE: WST ) today annou...ef Financial Officer, and Michael Anderson, Vice P...vices, Inc., will be presenting at,the CJS Securit... conference will be available through the Investor...
...y-stage patients who don,t yet need dialysis, stud...ws) -- Monitoring levels of a hormone called fibro...reatment of kidney failure patients, say Massachus...s were much more likely to die within the first ye...
Other Medicine News:Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 2Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 3Health News:SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation 2Health News:SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation 3Health News:Insurance Giant Leverages Technology to Enhance Offerings 2Health News:Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer 2Health News:Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer 3Health News:Monitoring Hormone May Improve Kidney Failure Outcomes 2
(Date:12/2/2009)... HAIFA, Isreal, December 2 /PRNewswire-FirstCall/..., a leading developer of advanced,cardiovascular s...y,s Board,of Directors approved a one-for-three fo..., payable to Cardio Vascular Medical Device shareh...e course the estimated date the stock,split will b...
(Date:12/2/2009)...VILLAGE, Nev., Dec. 2 PD...ounced that it has established the per share amoun... dividend as $1.67 per share. The dividend will be...ompany,s stock as of the December 1, 2009 record d...te per share amount of the dividend at $1.67 per s...
(Date:12/2/2009)...TON, Calif., Dec. 2 Roch...t the United States Food & Drug Administration... licensed nucleic acid test, to screen source plas...ions. The test, called the cobas® TaqScreen M...qualitative, in-vitro test for the simultaneous, d...
Breaking Medicine Technology:Cardio Vascular Medical Device Announces Forward Stock Split 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Hospital Group Receives 241 Million Grant to Help Patients Access Health Insurance 58697 1Hospital Group Receives 241 Million Grant to Help Patients Access Health Insurance 58697 24 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 14 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 24 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 3Thousands of Dental Professionals Arrive in Honolulu for ADAs 150th Annual Session 58693 1Thousands of Dental Professionals Arrive in Honolulu for ADAs 150th Annual Session 58693 2
...2007 - Researchers at,the Stanford University Scho...om their new study indicating that an antidepressa...behavioral disorder,known as compulsive buying, di...ts who took it., The medication is escitalopram, a... brand name Lexapro. In the study,researchers fou...
...ng for C1-inhibitor,replacement therapy, NEW YORK,...maceuticals, Inc. (Lev) today announced positive r...-esterase inhibitor (C1-INH),for the acute treatme...udy, which is part of the company,s CHANGE trials,...ion Generation,evaluating Efficacy), the protocol-...
Other Medicine Technology:Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 2Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5
Blue Line® Intubation Stylet 7.5 mm 10 mm
Blue Line® Intubation Stylet 2.5 mm 4.5 mm
Surch-Lite™ Flexible Light - 15" Sterile
Surch-Lite™ Flexible Light - 5" Non-Sterile
Medicine Products: